Association of IRF5 polymorphisms with activation of the interferon alpha pathway - Wikidata - wikimedia - TriplyDB

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

http://www.wikidata.org/entity/Q35102479

about

Solving the genetic puzzle of systemic lupus erythematosus.A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus.RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share Interferon regulatory factors in human lupus pathogenesis Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Genetic susceptibility to systemic lupus erythematosus in the genomic era Type I interferon and systemic lupus erythematosus.Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus.Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women.Pleiotropic IFN-dependent and -independent effects of IRF5 on the pathogenesis of experimental lupus IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection.Interferon regulatory factor 5 in the pathogenesis of systemic lupus erythematosus.Childhood onset systemic lupus erythematosus: how is it different from adult SLE?Identification of three new cis-regulatory IRF5 polymorphisms: in vitro studies.Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: analysis of multiple experiments with lymphoblastoid cell lines.Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus Interferon regulatory factor 5 polymorphisms in sarcoidosis.Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection.Recent insights into the genetic basis of systemic lupus erythematosus.

P2860

Q33359121-74D7C2F8-7854-4F93-AE0E-7D4752B64150 Q33954454-8F22C16D-BF77-4803-B880-213529900B04 Q34563170-BCBB14D1-8FF3-44A3-A7B8-5FA33FFE323E Q34764041-336A2EF4-380C-4B62-8750-EF483CD6BDCB Q34988497-F7C2F3B0-F354-4616-8442-0882DB5CADE2 Q35008001-2FE4D4CE-E66D-46CC-932A-FC2A815385DB Q35102487-6902C5E9-550E-49F6-9392-E72565636F96 Q35549980-74F67F35-A71B-474F-B61F-7F20C4E02C3D Q35743904-3CB54067-E6F1-4927-B248-52FA42D7A21B Q36302403-5D03FE9D-611B-46BF-BE11-6AE7324F7A10 Q36632390-B2C2C022-54DC-421B-B571-8B2D9AF0E045 Q37444269-999AA688-A323-46EC-96FC-1AED0A082D52 Q38068405-DB2493D7-4968-4179-92F8-E1A5B7A4CBB4 Q38223293-48F02914-06C0-4CBB-8ADE-C6D00659F8FB Q38650325-0A2973B1-2454-4F85-8644-19B3741C1F88 Q39185454-9AB692FD-55CF-4AB1-A30E-3532CF9ABA35 Q42668884-AF407AB9-7B85-43C5-8535-0A681CBEF9DB Q43699588-E041EC18-3C8C-40BE-8077-DC1178D118FA Q45372857-683FC4F5-C628-485B-87F6-DEC2C2C1D7E3 Q47548530-9F3B27F3-898E-4F40-876B-A2367EEAA2F7 Q55092643-53618055-577D-43B4-9385-7366C0EFD734

P2860

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

http://www.wikidata.org/entity/Q35102479

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@ast

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@en

type

label

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@ast

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@en

prefLabel

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@ast

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@en

P1433

Q35102479-61B25429-86F2-47B7-8B33-19022E1CB8B1

P1476

Q35102479-71A5F0F2-B4F7-4591-A08E-A88A86F3F84E

P2093

Q35102479-026BCFEE-9557-441D-9014-B15E314BB74F

Q35102479-0535C0EB-56F9-4541-A38E-CAE5BA39755E

Q35102479-0859D92D-E169-4FF2-83E1-1EB80EE40EB9

Q35102479-198AD4F9-24D0-464A-BD89-B7911FEE1288

Q35102479-3FB5F6DC-C9DA-48E4-A5F8-CCE22A925817

Q35102479-57FEC508-BC2E-472A-AB5E-E37AF55DD2FE

Q35102479-5B2F5E5B-88EE-4845-9DB8-371F63AF3977

Q35102479-7B335A1A-86CD-4F78-9E16-4B57AF7F7178

Q35102479-897CC4FD-F82F-4BFF-B909-883EB3E57AAD

P2860

Q35102479-07D4435A-E265-4492-8A68-D6BC723036C0

Q35102479-154A73C9-A1E0-4BC8-B1AE-47C613C2452D

Q35102479-166920FB-2087-40FE-B9F7-E7EEDC039FEE

Q35102479-2408102B-1EBB-4F7A-976C-E191AE303A89

Q35102479-250E9B56-F0AD-43C0-BC9E-06C32AD62B78

Q35102479-27AF43E7-5795-4BD6-BB19-ED2B46400E9D

Q35102479-2A74C22B-76B5-4859-B3D3-62A529BA8260

Q35102479-30B99A5B-34C6-4A51-92D0-4CE31D12100D

Q35102479-3BF5D725-4A28-4ABD-B67B-F5E387635534

Q35102479-3D6F8772-59C8-4CF4-9C19-BF334B81D306

P304

Q35102479-8B2BF979-31E4-422D-8365-9E0EF0113D9C

P31

Q35102479-BDAEBE94-2D82-4B8A-80EF-6A0AA49E6DB9

P356

Q35102479-83E4A220-1C95-4D9A-8AF0-E3A47E8C1FA0

P407

Q35102479-7E4DE74A-6AFE-4301-A51D-A74A23C9E812

P433

Q35102479-88053134-75F9-437B-AA04-FD5712C42B0F

P478

Q35102479-397924BE-4C53-4EDF-865A-024EE7390877

P577

Q35102479-CAEBE7D8-12CA-4443-93C3-C6891131CC5B

P5875

Q35102479-A86FAD05-9407-4DF3-A1E2-89F73CAD6DD0

P698

Q35102479-647C03E0-C0C7-4D19-8864-ACC7FE7CF1C8

P932

Q35102479-F8A01213-52BF-4423-B8EF-DAFF4CC6CDD7

P356

ARD.2009.118315

P1433

Annals of the Rheumatic Diseases

P1476

Association of IRF5 polymorphisms with activation of the interferon alpha pathway

@en

P2093

Alice D C Hoftman

http://www.w3.org/2001/XMLSchema#string

Betty P Tsao

http://www.w3.org/2001/XMLSchema#string

Brittany A Brahn

http://www.w3.org/2001/XMLSchema#string

Deborah McCurdy

http://www.w3.org/2001/XMLSchema#string

Hui Wu

http://www.w3.org/2001/XMLSchema#string

Jennifer M P Woo

http://www.w3.org/2001/XMLSchema#string

Ornella J Rullo

http://www.w3.org/2001/XMLSchema#string

Paul Maranian

http://www.w3.org/2001/XMLSchema#string

Rita M Cantor

http://www.w3.org/2001/XMLSchema#string

P2860

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus

Common genetic variants account for differences in gene expression among ethnic groups

Systemic lupus erythematosus and the type I interferon system

Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history

The International HapMap Project

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus

P304

611-617

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/ARD.2009.118315

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38034154

http://www.w3.org/2001/XMLSchema#string

P698

19854706

http://www.w3.org/2001/XMLSchema#string

P932

3135414

http://www.w3.org/2001/XMLSchema#string